NCT03850691 2024-01-17
Radiation and Combination Immunotherapy for Melanoma
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
Masonic Cancer Center, University of Minnesota
Celgene
Zydolab - Institute of Cytology and Immune Cytochemistry